Previous close | 19.76 |
Open | 19.78 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 19.60 - 20.30 |
52-week range | 17.88 - 40.00 |
Volume | |
Avg. volume | 27,394 |
Market cap | 341.669M |
Beta (5Y monthly) | 1.86 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.96 |
Earnings date | 11 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Clermont-Ferrand, France, 19 April 2024 (18.30 CEST). Carbios (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastics and textiles, announces to its shareholders and the financial community that its 2023 Universal Registration Document including the annual report, the management report and the report on corporate governance was filed with the French Financial Market Authority (Autorité des marchés financ
CARBIOS wins "So French So Innovative" award at InnoEX 2024, Hong Kong Dr. Bruno LANGLOIS, Technologies & Institutional Partnerships Director for CARBIOS (center), receiving the « So French So Innovative » Award on behalf of CARBIOS at InnoEX 2024, Hong Kong. CARBIOS wins "So French So Innovative" award at InnoEX 2024, Hong Kong, recognizing French innovation in Asia Pacific Clermont-Ferrand, France, Tuesday 16 April 2024 (6.30pm CET) CARBIOS (Euronext Growth Paris: ALCRB), a pioneer in the deve
CARBIOS Group’s solid financial structure: cash position of €192 million on December 31, 2023Construction progress of world’s first PET1 biorecycling plant in France: in line with delivery targets for customers in 2026Licensing: international sales teams deployed in more than ten countries, with several partnerships feasible for 2024 Clermont-Ferrand, France, April 11, 2024 (6:45 a.m. CEST) - CARBIOS (Euronext Growth Paris: ALCRB), a biotech company developing and industrializing biological solu